Multiple endocrine neoplasia type 2

The National Osteoporosis Foundation (NOF) Announces Dr. Robert Gagel as the 2019 Recipient of its Lawrence G. Raisz Memorial Lecture Award

Retrieved on: 
Thursday, May 16, 2019
Glands, Organ systems, Endocrine system, Autosomal dominant disorders, Thyroid, Hereditary cancers, Multiple endocrine neoplasia type 2, Medullary thyroid cancer, Calcitonin, Multiple endocrine neoplasia

ARLINGTON, Va., May 16, 2019 /PRNewswire/ -- The National Osteoporosis Foundation (NOF) announces Robert Gagel, MD, Professor of Medicine at MD Anderson Cancer Center, Adjunct Professor in the Department of Cell Biology at Baylor College of Medicine and NOF Trustee, as the recipient of its 2019 Lawrence G. Raisz, MD Memorial Lecture Award.

Key Points: 
  • ARLINGTON, Va., May 16, 2019 /PRNewswire/ -- The National Osteoporosis Foundation (NOF) announces Robert Gagel, MD, Professor of Medicine at MD Anderson Cancer Center, Adjunct Professor in the Department of Cell Biology at Baylor College of Medicine and NOF Trustee, as the recipient of its 2019 Lawrence G. Raisz, MD Memorial Lecture Award.
  • "We are thrilled to announce Dr. Gagel as the recipient of NOF's highest scientific award, the Lawrence G. Raisz, MD Memorial Lecture Award," said Elizabeth Thompson, CEO, NOF.
  • Dr. Gagel is a renowned medical expert in Multiple Endocrine Neoplasia Type 2 (MEN2) and medullary thyroid carcinoma, as well as bone biology and calcitonin.
  • For more information on the National Osteoporosis Foundation, visit www.nof.org .